These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Mycophenolate-induced oral ulcers: Case report and literature review. Asare K; Gatzke CB Am J Health Syst Pharm; 2020 Mar; 77(7):523-528. PubMed ID: 32058566 [TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil-induced mouth ulcers in a kidney transplant patient: Case report and literature review. Plana-Pla A; Solé LC; Garcia AB; Valdemoros RL Nefrologia (Engl Ed); 2019; 39(1):80-83. PubMed ID: 30082101 [TBL] [Abstract][Full Text] [Related]
11. Use of mycophenolate mofetil in liver transplantation: a literature review. Manzia TM; De Liguori Carino N; Orlando G; Toti L; De Luca L; D'Andria D; Cardillo A; Anselmo A; Casciani CU; Tisone G Transplant Proc; 2005; 37(6):2616-7. PubMed ID: 16182764 [TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy and safety of mycophenolate mofetil in liver transplant recipients with calcineurin inhibitor-induced renal dysfunction. Koch RO; Graziadei IW; Schulz F; Nachbaur K; Königsrainer A; Margreiter R; Vogel W Transpl Int; 2004 Oct; 17(9):518-24. PubMed ID: 15365603 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of oral ulcerations associated with mycophenolate mofetil in kidney transplantation. Tenório JR; Tuma M; Martins F; Ortega KL; Cristelli M; Gallottini M Spec Care Dentist; 2020 Nov; 40(6):605-610. PubMed ID: 32950040 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of mycophenolate mofetil as part of induction therapy in liver transplantation. Pareja-Ciuró F; Díez-Canedo JS; Gómez-Bravo MA; García-Gonzalez I; Tamayo-López MJ; Sousa-Martín JM; Pascasio-Acevedo JM; Porras-Lopez MF; Gavilán-Carrasco F; Bernardos-Rodríguez A Transplant Proc; 2005 Nov; 37(9):3926-9. PubMed ID: 16386587 [TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial. Sterneck M; Fischer L; Gahlemann C; Gundlach M; Rogiers X; Broelsch C Ann Transplant; 2000; 5(1):43-6. PubMed ID: 10850611 [TBL] [Abstract][Full Text] [Related]
17. Oral Ulcerations Induced by Mycophenolate Mofetil Following Cardiac Transplant. Mahdavi M; Hejri GM Exp Clin Transplant; 2016 Oct; 14(5):584-585. PubMed ID: 27733108 [No Abstract] [Full Text] [Related]
18. Efficacy of mycophenolate mofetil combined with very low-dose cyclosporine microemulsion in long-term liver-transplant patients with renal dysfunction. Cantarovich M; Tzimas GN; Barkun J; Deschênes M; Alpert E; Tchervenkov J Transplantation; 2003 Jul; 76(1):98-102. PubMed ID: 12865793 [TBL] [Abstract][Full Text] [Related]
19. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years. Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230 [TBL] [Abstract][Full Text] [Related]
20. Lessons from a transplant patient with diarrhea, cryptosporidial infection, and possible mycophenolate mofetil-associated colitis. Frei P; Weber A; Geier A; Mertens JC; Kohler S; Rogler G; Müllhaupt B Transpl Infect Dis; 2011 Aug; 13(4):416-8. PubMed ID: 21615846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]